Stock 301235 WUHAN HUAKANG CENTURY MEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Wuhan Huakang Century Medical Co., Ltd.

Equities

301235

CNE1000057D4

Construction & Engineering

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
18.1 CNY +2.84% Intraday chart for Wuhan Huakang Century Medical Co., Ltd. -5.33% -29.38%
May. 30 Huakang Century Medical Bags Laboratory Renovation Project for 80 Million Yuan MT
May. 24 Wuhan Huakang Century Medical Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 30 May 2024 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 3,777 2,707 1,911 -
Enterprise Value (EV) 1 3,777 2,707 1,911 1,911
P/E ratio 36.1 x 25.1 x 8.34 x 5.36 x
Yield - - - -
Capitalization / Revenue 3.18 x 1.69 x 0.72 x 0.52 x
EV / Revenue 3.18 x 1.69 x 0.72 x 0.52 x
EV / EBITDA 31.1 x 19.6 x 5.66 x 4.2 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book 2.29 x 1.54 x 0.94 x 0.8 x
Nbr of stocks (in thousands) 105,600 105,600 105,600 -
Reference price 2 35.77 25.63 18.10 18.10
Announcement Date 4/24/23 4/26/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 1,189 1,602 2,642 3,690
EBITDA 1 121.6 138.3 337.7 455.4
EBIT 1 114.4 122.8 273.6 404.9
Operating Margin 9.62% 7.67% 10.35% 10.97%
Earnings before Tax (EBT) 1 117.5 121.1 266.3 415
Net income 1 102.5 107.3 229 356.9
Net margin 8.62% 6.7% 8.67% 9.67%
EPS 2 0.9900 1.020 2.170 3.380
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 4/24/23 4/26/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) 6.76% 6.31% 11.3% 15%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 15.70 16.60 19.20 22.60
Cash Flow per Share 2 -3.240 -1.770 -3.270 -3.270
Capex 1 - - 1.81 0.55
Capex / Sales - - 0.07% 0.01%
Announcement Date 4/24/23 4/26/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Wuhan Huakang Century Medical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
18.1
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Construction & Engineering

1st Jan change Capi.
WUHAN HUAKANG CENTURY MEDICAL CO., LTD. Stock Wuhan Huakang Century Medical Co., Ltd.
-29.38% 264M
VINCI Stock VINCI
-7.83% 68.29B
LARSEN & TOUBRO LIMITED Stock Larsen & Toubro Limited
+0.43% 58.15B
QUANTA SERVICES, INC. Stock Quanta Services, Inc.
+25.55% 39.43B
CHINA STATE CONSTRUCTION ENGINEERING CORPORATION LIMITED Stock China State Construction Engineering Corporation Limited
+16.63% 32.22B
FERROVIAL SE Stock Ferrovial SE
+9.21% 28.61B
CHINA RAILWAY GROUP LIMITED Stock China Railway Group Limited
+17.61% 21.32B
WSP GLOBAL INC. Stock WSP Global Inc.
+11.89% 18.85B
CHINA COMMUNICATIONS CONSTRUCTION COMPANY LIMITED Stock China Communications Construction Company Limited
+45.11% 17.73B
EMCOR GROUP, INC. Stock EMCOR Group, Inc.
+74.30% 17.67B
Other Construction & Engineering
  1. Stock Market
  2. Equities
  3. 301235 Stock
  4. Financials Wuhan Huakang Century Medical Co., Ltd.